Clinical Trial Update: A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating enzalutamide alone, enzalutamide with mifepristone, or chemotherapy in people with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Mifeprex (mifepristone)
• Xtandi (enzalutamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING